Assignee
SBI BIOTECH CO LTD
JP·6 granted patents·8 pending applications·1 citations·filing 2012–2021
Top patents by PatentIndex Score
14 records- 0165US2020339682A1Anti-ilt7 antibodySBI BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 0264US9944715B2Anti-phospholipase D4 antibodySBI BIOTECH CO LTD·Filed 2013·Granted Apr 17, 2018·1 cites·10 claims
- 0361US2021130493A1Medicament comprising anti-phospholipase d4 antibodySBI BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 0457US2013259872A1Anti-ilt7- antibodySBI BIOTECH CO LTD·Filed 2013·Application pending·0 cites
- 0555US2017204179A1Anti-ilt7 antibodySBI BIOTECH CO LTD·Filed 2016·Application pending·0 cites
- 0652US2016130343A1Anti-ilt7 antibodySBI BIOTECH CO LTD·Filed 2015·Application pending·0 cites
- 0749US2023323368A1Novel tlr9 agonistsSBI BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 0848US10730955B2Polynucleotides encoding anti-human receptor-type protein tyrosine phosphatase sigma antibodiesSBI BIOTECH CO LTD·Filed 2017·Granted Aug 4, 2020·0 cites·8 claims
- 0947US10190122B2Inhibitory oligonucleotide and use thereofSBI BIOTECH CO LTD·Filed 2017·Granted Jan 29, 2019·0 cites·18 claims
- 1047US2016168266A1Medicament comprising anti-phospholipase d4 antibodySBI BIOTECH CO LTD·Filed 2014·Application pending·0 cites
- 1145US10336834B2Methods of using anti-phospholipase D4 antibodiesSBI BIOTECH CO LTD·Filed 2018·Granted Jul 2, 2019·0 cites·7 claims
- 1245US9688992B2Inhibitory oligonucleotide and use thereofSBI BIOTECH CO LTD·Filed 2012·Granted Jun 27, 2017·0 cites·25 claims
- 1340US10806749B2TLR inhibitory oligonucleotides and their useSBI BIOTECH CO LTD·Filed 2016·Granted Oct 20, 2020·0 cites·6 claims
- 1431US2017240896A1Inhibitory Oligonucleotides for Treating TumorsSBI BIOTECH CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SBI BIOTECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →